论文部分内容阅读
目的:探讨“计划-实施-检验-改进(PDCA循环)”在提高妇科备置高危药品安全管理中应用,旨在为保障患者用药安全提供借鉴。方法:将2014年1~10月PDCA循环实施后舟山医院妇科护理管理工作列为观察组,期间住院患者816例;回顾性分析2013年1~10月PDCA循环实施前的妇科护理管理工作,将其列为对照组,期间住院患者783例。对照组予以常规护理管理模式,观察组在此基础上针对妇科高危药品管理风险因素实施PDCA循环。比较两组高危药品管理相关负性事件,包括高危药品失效、基数不符、标识不清/不全、存放不当、高危药品临界差错等,以及两组药品护理管理评分、护理满意度评分,满分均为100分。结果:除药品失效外,观察组高危药品基数不符、标识不清/不全、存放不当、临界差错的比例均低于对照组(P<0.05)。观察组药品护理管理评分、护理满意度评分为(95.22±2.00)分、(97.46±1.20)分,对照组分别为(87.38±4.15)分、(90.71±3.35)分,观察组药品护理管理评分、护理满意度评分均高于对照组(P<0.05)。结论:将PDCA循环引入妇科备置高危药品安全管理不仅降低了相关负性事件的发生率,提高了高危药品的使用安全,提高了整体药品护理管理的水平,保障了患者的用药安全,同时也提高了护理满意度,达到了预期的干预效果。
Objective: To explore the application of “plan-implement-test-improve (PDCA cycle)” in improving the safety management of high-risk medicines for gynecological replacement, which aims to provide reference for the protection of patients’ medication safety. Methods: The gynecological nursing management of Zhoushan Hospital after the implementation of PDCA cycle from January to October in 2014 was listed as observation group with 816 inpatients during the period from January 2014 to October 2014. The retrospective analysis of gynecological nursing management before PDCA cycle from January to October 2013 was conducted. As a control group, 783 inpatients during the period. The control group was given routine nursing management mode, on the basis of which the observation group conducted the PDCA cycle for the risk factors of gynecological high-risk drug management. The two groups of negative events related to the management of high-risk drugs were compared, including the failure of high-risk drugs, inconsistency of base number, unclear / incomplete identification, improper storage, critical errors of high-risk drugs and two groups of drug administration management scores and nursing satisfaction ratings, 100 points. Results: In addition to the failure of drugs, the observation group of high-risk drug base does not match, the mark is not clear / incomplete, improper storage, the proportion of critical errors were lower than the control group (P <0.05). (95.22 ± 2.00) points and (97.46 ± 1.20) points in the observation group and (87.38 ± 4.15) points and (90.71 ± 3.35) points in the control group respectively. The score of the drug nursing management score , Nursing satisfaction scores were higher than the control group (P <0.05). Conclusions: The introduction of PDCA cycle into the safety management of high-risk medicines for gynecological replacement not only reduces the incidence of related negative events, improves the safety of high-risk drugs, improves the level of overall drug management and care, and ensures the safety of patients’ medication, meanwhile Improve nursing satisfaction and achieve the expected effect of intervention.